BioVoice News July 2017 Issue 2 Volume 2 | Page 28

bio chat overall cost of the tests and hence, to make them affordable for everyone is the biggest challenge for us. Is the cost effectiveness still an issue as far as poorer sections of society are concerned? How are you addressing the balancing act between quality and yet affordable price? As a service provider, affordability to everyone is one of our prime focus, but, it is one of the major challenges to sustain in the business in this industry. I think government’s new healthcare policy will help to bridge that gap. Being in the healthcare domain, we cannot compromise on the quality, because our results will change the lives of many. We 28 BioVoiceNews | July 2017 always maintain it as per the international standards and try to We remain committed to bring the most advanced technologies to India, validate them for the Indian environment and then ensure its availability to the masses at a very affordable price make it affordable. We offer customized solutions at all levels of the healthcare platform be it a super- specialty hospital, clinics, day care centers, wellness & lifestyle clinics (both rural and urban). How do you analyse the latest trends in medical diagnostics in India? Where is the market heading to? The bridge between innovation globally and in India is filling at a very faster pace. The Indian market is evolving and maturing as per the Indian appetite. Sequencing is nowadays a major trend, especially in high-end diseases. We are slowly entering the clinical space from being only academic and research organization centric. Today, the diagnostics are more technology- driven and hence, we are moving from being a pure play hardware- driven business to a technology-enabled business. The use of